Omada Health shares fall 2.23% intraday after Baird initiates coverage with a Neutral rating and $24 price target.

Omada Health, Inc. declined 2.23% in intraday trading, with Baird initiating coverage on the stock with a Neutral rating and a $24 price target. This news event is likely bearish for the stock, as a Neutral rating suggests that the stock is expected to perform in line with the market, rather than outperform it.